Ibandronic Acid bulk supplier for pharma manufacturers

Ibandronic Acid Suppliers & Bulk Manufacturers

Available Forms: Oral tablet and Intravenous injection

Available Strengths: Tablet: 150 mg; Injection: 3mg/3ml

Reference Brands: Boniva® (US & EU); Bondronat®(EU)

Ibandronic Acid (Bonviva® in the EU, Boniva® in the US) is a bisphosphonate used to treat and prevent postmenopausal osteoporosis. It reduces bone loss and fracture risk by inhibiting osteoclast activity. Available as a 150 mg oral tablet (monthly) or 3 mg IV injection (quarterly), it offers flexible dosing and high patient adherence. Widely marketed by Roche, it is a trusted option in B2B women’s health distribution across Europe and the United States.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Ibandronic Acid (marketed as Bonviva® in the EU and Boniva® in the US) is a bisphosphonate used for the treatment and prevention of postmenopausal osteoporosis. It works by inhibiting osteoclast-mediated bone resorption, increasing bone mineral density and reducing the risk of vertebral fractures. Available in oral 150 mg monthly tablets and 3 mg quarterly IV injections, Ibandronic Acid offers flexible dosing options to improve patient compliance. It is marketed in both regions by Roche and its affiliates, ensuring consistent quality and regulatory compliance. Ibandronic Acid is widely adopted in B2B pharmaceutical distribution for women’s health across Europe and North America.

Ibandronic Acid — third party manufacturing & bulk supply

Ibandronic Acid is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ibandronic Acid is supplied as Oral tablet and Intravenous injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ibandronic Acid listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ibandronic Acid →

Back to Listing

Frequently Asked Questions

Ibandronic Acid is listed as Oral tablet and Intravenous injection in Tablet: 150 mg; Injection: 3mg/3ml. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ibandronic Acid is referenced against Boniva® (US & EU); Bondronat®(EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.